Fluorocyanoacrylates
Folder:
Year:
Abstract:
Fluorinated cyanoacrylates having the formula:
-------
wherein R is hydrogen, methyl or ethyl, R' is fluorine, -CF3 or -(CF2)nH, and n is an integer from 1 to 3 have been found to be useful adhesives which when applied as monomers to adherends rapidly polymerize in the presence of even small amounts of e.g. moisture to form strong bonds. The monomers also polymerize to films and can be used biologically as hemostatics and tissue adhesives.
Type of document:
Language:
United States Patent Ofice
3,639,361
Patented Feb. 1, 1972
1
3,639,361
FLUOROCYANOACRYLATES
Jerry E. Robertson, North Oaks, Joseph Kenneth Harring-
ton, Edina, and Elden H. Banitt, Woodbury Township,
Washington County, Minn., assignors to Minnesota
Mining & Manufacturing Company, St. Paul, Minn.
No Drawing. Filed Dec. 1, 1967, Ser. No. 687,111
Int. Cl. C08f 3/42
U.S. Cl. 260—78.4 12 Claims
ABSTRACT OF THE DISCLOSURE
-Fluorinated cyanoacrylates having the formula
CN R
l I
CH2=C—C 02-CH-—C F2R'
wherein R is hydrogen, methyl or ethyl, R’ is fluorine,
—CF3 or —(CF2),,H, and n is an integer from 1 to 3
have been found to be useful adhesives which when ap-
plied as monomers to adherends rapidly polymerize in
the presence of even small amounts of e.g. moisture to
form strong bonds. The monomers also polymerize to
films and can be used biologically as hemostatics and
tissue adhesives.
FIELD OF THE INVENTION
This invention relates to compositions which polymer-
ize to form coatings and adhesives. More particularly, the
invention relates to fluorine-containing cyanoacrylate mon-
omers which polymerize rapidly upon contact with basic
materials, e.g. moisture in the air, to form polymers
which are suitable for biological application, i.e. to bond
or coat living mammalian tissues.
The fluorinated 2-cyanoacrylates of this invention are
useful in adhesive compositions and are particularly use-
ful as biological adhesives and hemostatic agents. Thus,
new approaches to the joining together of mammalian
tissues, as well as for arresting the escape of blood there-
through, are possible by the use of these novel mono-
mers. For example, satisfactory hemostasis of splenic
and liver wounds, heretofore to a great extent unrepair-
able by conventional methods, is obtained by the appli-
cation and polymerization of a thin film of fluorinated
2-cyanoacrylate monomer on the injured surface. The
bonding strength, absorbability by the tissues, hemo-
static capability and low degree of local inflammation re-
sulting when these monomers are applied in vivo, are
properties which make them especially valuable for bio-
logical applications.
PRIOR ART
Known non-fluorinated alkyl 2-cyanoacrylates, particu-
larly the methyl, isobutyl and n-butyl 2-cyanoacrylates,
have been investigated for use as biological adhesives,
see, e.g. Medical World News, 8 (20), 41 (1967); Mfg.
Chemist, 38 (8), 94 (1967); Technical Report 6618,
Walter Reed Army Medical Center, December 1966.
While the unsubstituted alkyl monomers appear to pos-
sess the requisite bonding and hemostatic properties when
applied to damaged mammalian tissues, these materials
appear to fail to have the required properties of low
toxicity and adequate absorption by the tissues. Methyl 2-
cyanoacrylate, for example, gives rise to a severe in-
flammatory tissue response at the site of application. The
n-butyl and isobutyl 2-cyanoacrylate monomers are not
absorbed well (if at all) by the tissues and polymeric
residue of the adhesive has been observed by histologic
examination of the site of application as much as twelve
months after surgery, see, e.g. {Medical World News, 8
(29), 27 (1967).
U!
10
15
20
NJ
Cl
30
C6
C4‘!
40
50
60
65
2
It is accordingly an object of this invention to provide
new monomers which are suitable for use in biological
adhesive compositions and which form adhesive bonds
which do not significantly interfere with natural healing
of injured mammalian tissues, are readily assimilated by
the body with minimal toxic effects, and are autopolymer-
izable in the presence of blood and other body fluids.
The present invention also contemplates providing new
monomeric adhesives which can be used alone, or in
conjunction with each other or in conjunction with un-
substituted alkyl 2-cyanoacrylates in the bonding of dam-
aged mammalian tissue or in preventing the escape of
blood or other fluids therethrough and which are auto-
polymerizable in thin film on said tissue. Comonomer
compositions are of interest for specific uses because
they may provide advantageous combinations of proper-
ties not completely embodied in individual monomers.
A further object of this invention is to provide new
monomeric adhesives which can be used either alone or
as comonomers in the bonding of similar or dissimilar
materials without the use of heat or catalyst during the
bonding operation.
Other objects will be apparent from the description and
claims which follow, e.g. the prepartion of polymers.
SUMMARY OF THE INVENTION
The present invention is based on the discovery that
the replacement of hydrogen atoms in the alcoholic resi-
due of 2-cyanoacrylate esters with fluorine atoms unex-
pectedly renders these monomers substantially better
tolerated by living tissue than are the hydrocarbon mono-
mers. ".,!|; K‘
The class of monomeric 2-cyanoacrylate esters which
comprises this invention is represented by the structural
formula
(EN Ii
CH2=C—-C 02—CH—C F2R’
wherein R is a member of the group consisting of hy-
drogen, methyl or ethyl and R’ is a member of the group
consisting of fluorine, —(CF2),,H and CF3 and n is an
integer from 1 to 3. These new fluorinated monomers
when employed in biological adhesive compositions, in-
dividually or as comonomers, exhibit excellent skin wound
adhesion and hemostasis; they are well assimilated by the
tissues at an acceptable rate, and their use, particularly
in the case of the monomers in which the
1?
——CH—CF2R’
radical is —CH2(CF2)4H-1,1,5-trihydroperfluoropentyl 2-
cyanoacrylate, —CHgCF2CF3~l,1-dihydroperfluoropropyl
2-cyanoacrylate, —-CH2 (CF 2) 2H-1 , 1,3-trihydroperfluoro-
propyl 2-cyanoacrylate and —CH(CH3)CF3-2-(1,1,l-tri-
fluoro)propyl 2-cyanoacrylate produces minimal local
tissue inflammation in mammals. The —~OH2CF3 group-
containing monomer, 2,2,2-trifluoroethyl cyanoacrylate,
while exhibiting a relatively higher degree of inflammatory
tissue response in subcutaneous tissues of mice, was com-
pletely biodeg-raded by the exposed surface of partially
excised rat livers within sixteen weeks after application
of the monomer. The degree of local inflammation caused
by the latter monomer, however, is still less than that
caused by methyl 2-cyanoacrylate as determined by gross
and microscopic examinations.
In most bonding applications employing monomers of
the invention, polymerization is catalyzed by small
amounts moisture on the surface of the adherends. Thus a
drop of monomer can be placed on the surface of e.g. one
of two metal or glass pieces which are to be adhered and
3,639,361
3
the other piece brought into contact therewith. A strong
bond is soon formed by polymerization.
Similarly, desired bonding of tissues or hemostasis
proceeds well in the presence of blood and other body
fluids. The bonds formed are of adequate flexibility and
strength to withstand normal movement of tissue. In addi-
tion, bond strength is maintained as natural wound heal-
T ing proceeds concurrently with polymer assimilation.
Compositions of the invention are sterilizable by con-
ventional methods such as distillation under aseptic con-
ditions. ,
The method of repairing injured tissues with composi-
tions of this invention (for example, to control bleeding)
comprises, in general, sponging and subsequent applica-
tion to the tissue of an adhesive composition containing a
monomer of the invention which polymerizes to a thin
film of polymer while in contact with said tissue surfaces.
For bonding separate surfaces of body tissues, the mono-
mer would be applied to at least one of such surfaces, and
the surfaces brought quickly together while the monomer
polymerizes in contact with both of the surfaces.
The monomers of the invention are eflfective in adhesive
formulations with the fluoroalkyl 2-cyanoacrylates as the
major active constituent. Thus, the cyanoacrylate may be
combined in admixture with a polymerization-inhibitor
(e.g. sulfur dioxide). One or more adjuvant substances,
such as thickening agents, plasticizers, or the like, to im-
prove the surgical utility of the monomer, can also be
present.
Depending on the particular requirements of the user,
these adhesive compositions can be applied by known
means such as with a glass stirring rod, sterile brush or
medicinal dropper; however, in many situations -a pres-
surized aerosol dispensing package is preferred in which
the adhesive composition is in solution with a compatible
anhydrous propellant.
The monomers are readily polymerized to addition-type
, polymers and copolymers, which are generally optically
clear (as films) and are thermoplastic and moldable at
temperatures below their decomposition temperature.
They can be shaped at temperatures in the range of 100°
to 150° C‘.
The polymers have the general formula
wherein R and R’ are as defined above and x is a number
from 5 to 500.
Polymerization occurs by free radical initiation, ex-
posure to small amounts of base, e.g. triethylamine, or
water. The liquid monomer can be spread on e.g. a poly-
ethylene surface and exposed to triethylamine to bring
about polymerization to a coating which can‘ be peeled
from the polyethylene as a self-supporting, optically clear
film.
The monomers of the invention can be copolymerized
with other acrylates or epoxides.
The preferred method for preparing high purity (95
percent or greater) fluoroalkyl 2-cyanoacylates comprises
catalyzing the condensation of formaldehyde with esters
of cyanoacetic acid by means of a mixture of an acid and
the acidic salt of an alkyl primary or secondary amine.
10
20
25
30
40
45
50
55
60
65
70
75
4
With particular reference to the preparation of the
fluoroalkyl 2-cyanoacrylate esters of the present inven-
tion, the preferred method of preparation employs the
cyanoacetates corresponding to the desired cyanoacrylates
(e.g. 2,2,2-trifluoroethyl cyanoacetate for 2,2,2—trifluoro-
ethyl 2-cyanoacrylate). The cyanoacetate is reacted with
formaldehyde or polymers thereof such as paraformalde-
hyde, excepting aqueous solutions of formaldehyde as typi-
fied by formalin. The reaction medium may be any suit-
able inert organic solvent capable of forming an azeotrope
with water.
The essential feature of the synthesis is the particular
combination of catalytic materials employed. Any acid
salt of an alkyl primary or secondary amine and any free
acid may be utilized as components of the catalytic mix-
ture, provided they establish the necessary pH value as
described in detail below.
All phases of the synthetic sequence are carried out
under acidic conditions. A criterion for utility of the cata-
lytic mixture selected is that it have a corrected pH value
if not over pH 5. This pH value can be determined as fol-
ows:
The exact amounts of amine acid salt and free “acid to
be used in the condensation step are dissolved in 25 ml.
of water, and the pH of the solution is measured. If the re-‘
sulting pH value is 5 or less, the mixture will adequately
catalyze the condensation reaction. When the mixture is
soluble in water, this is the “corrected pH value.”
Catalytic mixtures comprising organic acids which are
not readily soluble in water may be dissolved in 25 ml. of
an ethanol-water mixture; however, the measured pH must
then be corrected as described by B. Gutbezehl and E.
Grunwald in J. Am. Chem. Soc., 75, 565 (1953).
Both primary or secondary amine salt and free acid are
always present. Glacial acetic or strong mineral acids such
as hydrochloric acid or sulfuric acid are preferred. The
amount of catalyst employed is not critical -and may be
varied. Ordinarily a small amount, e.g. 0.5 to 0.1 percent
by weight, based on the weight of cyanoacetic ester, is
adequate.
Other than employing the imine acid salt and free acid,
the condensation of cyanocacetic esters with formaldehyde
and the subsequent depolymerization process are carried
out by methods similar to prior art methods.
The following examples will illustrate preferred em-
bodiments of the invention. It will -be understood, how-
ever, that the examples are included merely for the pur-
poses of illustration and are not intended to limit the scope
of the invention, unless otherwise specifically indicated.
All parts are by weight unless otherwise specified, and the
pressures are shown in millimeters of mercury.
Example 1.—Fluoroalkyl cyanoacetates
Fluoroalkyl cyanoacetates required as starting materials
in the synthesis of fluoroalkyl 2-cyanoacrylates described
in this invention are not available by simple esterification
of cyanacetic acid. A general procedure for the special
preparation of these materials from cyanoacetyl chloride
on a large scale is given below. ’
A 5-1. three-necked, round-bottomed flask equipped
with an eflicient mechanical stirrer, large addition funnel
and reflux condenser topped with a gas exit tube was
charged with 1000 ml. of diethyl ether and 1042.5 g. of
phosphorus pentachloride. This suspension was stirred and
cooled in an ice bath. In a separate container, a solution
of 425.5 g. (5.0 moles) of cyanoacetic acid in 1750 ml.
of diethyl ether was dried over magnesium sulfate and
filtered to remove drying agent. It was then added over a
period of 3 to 7 minutes with good stirring to the cold
suspension. (The exothermic reaction which occurs can
be controlled by adjusting the rate of addition, but a rapid
rate is essential for optimum yield.) The condenser was
immediately replaced with a short head and condenser.
Ether and phosphorus oxychloride were then distilled off
3,639,361
5
under reduced pressure (aspirator) to afford crude cyano-
acetyl chloride as an orange-red, mobile liquid. During
this operation, the internal pot temperature was not al-
lowed to exceed 55° C. This step is critical since higher
temperatures will cause degradation of cyanoacetyl chlo-
ride and may induce exothermic and uncontrollable polym-
..erization. Samples of cyanoacetyl chloride should be used
directly after preparation and should not be stored.
The distillation apparatus was then removed from the
flask and replaced with a reflux condenser topped with a
gas exit tube. The selected fluoroalcohol was placed in the
funnel and about one-third added to the crude cyanoacetyl
chloride. If the reaction did not begin spontaneously as
evidenced by evolution of hydrogen chloride, the mixture
was heated to 55 °—65 ° C.; the remaining fluoroalcohol was
then added slowly to maintain a smooth reaction. After
completion of addition, the mixture was stirred at 55°-
65° C. until no more hydrogen chloride was evolved. The
acidic product was transferred to a smaller flask and crude-
ly distilled to afford fluoroalkyl cyanoacetate. Fractional
redistillation provided pure fluoroalkyl cyanoacetate with
yields in the range of 75-85 percent.
TABLE I
[Fluoroalkyl Cyanoaeetates, N C CH2C 02R]
R B .1’. (°C./mm.) ma 25°
-—-—CH2CFa ------- -— 93/9 1.3692
—CH2CF2C Fa.--. 83-85/6 1.3546
-—CH2(CF2)2H_._- 71/0.25 1.3785
—-CH2 (C F2) 4H- - . _ 105-106/0. 9 1. 3585
/CH3 96 /I3 1. 3724
—C1{
\
C F:
Example 2.—2-,2,2-trifluoroethyl 2-cyanoacrylate
Six hundredmilliliters of benzene, 167.1 g. (1.0 mole)
of 2,2,2-trifluoroethyl cyanoacetate, 36.0 g. (1.2 moles)
of powdered paraformaldehyde, 1.0 g. of piperidine hy-
drochloride and 0.2 ml. of glacial acetic acid were com-
bined in a 1-1. two-necketd, round-bottomed flask equipped
with mechanical stirrer, Dean-Stark water trap and re-
flux condenser. The heterogeneous mixture was stirred
and heated under gentle reflux until all water formed dur-
ing the reaction had been azeotropically removed and col-
lected in the Dean-Stark trap. -Only a portion of the poly
(trifluoroet-hyl 2-cyanoacrylate) formed in the reaction
separated; the remainder was precipitated by cooling the
flask in an ice bath.
After the cold benzene had been decanted, 300 ml. of
anhydrous acetone were added and warmed to dissolve
polymer. The clear polymer solution was filtered (to re-
move piperidine hydrochloride and any unreacted para-
formaldehyde) into a clean 1-1. two-necked, round-bot-
tomed flask equipped with mechanical stirrer, and 100 g.
of tricresyl phosphate were added to aid in fluidizing the
mixture. Acetone was then removed by distillation. Pres-
sure in the system was gradually reduced to 15-20 mm.
Hg, and the bath temperature slowly raised to 110°—120°
C. Last traces of acetone were eliminated by stirring the
yellow, viscous mixture vigorously for 30 minutes under
these conditions.
At this point, 6-10 g. of polyphosphoric acid and 0.5
g. of pyrogallol were added to serve as inhibitors, and the
flask was equipped with a short take-ofi head fitted with a
gas inlet tube mounted in the thermometer well. Thermal
depolymerization was effected by heating this mixture un-
der reduced pressure with good stirring while sulfur di-
oxide was bled into the system. Collection of monomeric
2,2,2-trifluoroethyl 2-cyanoacrylate in a Dry Ice-cooled re-
ceiver was begun when the bath temperature/system pres-
sure reached 155° C./ 20 mm. and continued up to .a maxi-
mum of 200° C./ 10 mm. Clear, colorless monomer ob-
tained in this fashion is sufficiently pure for most adhesive
applications; yield, 95 g. (53 percent based on 2,2,2-tri-
fluoroethyl cyanoacetate) .
10
15
20
30
40
45
50
60
65
70
75
6
Greater purity may be achieved by redistillation from
a small amount of phosphorus pentoxide using a short
Vigreux column. A sulfur dioxide bleed to serve as inhib-
itor and prevent anionic polymerization is essential dur-
ing any such redistillation. On redistillation, the distilla-
tion cut boiling at 83 °-84° C./13 mm. weighed 71 g. and
was shown to be 95.8 percent pure 2,2,2-trifluoroethyl
2-cyanoacrylate.
Monomer purity was established by gas chromatography
using a chromatograph equipped with a 6’ x 1/1" nitrile-
containing silicone column packed on diatomaceous earth
(of the type commercially available under the trade name
“60/ 70 Anakrom ABS”) and operated at column tempera-
tures of 150°—l90° C. Monomer samples were injected as
10 percent solutions in spectrograde nitromethane.
Polymeric 2,2,2-trifluoroethyl cyanoacrylate was formed
by pouring the monomer into a large excess of rapidly
stirred '1 :1 methanol-water solution. The polymer precipi-
tated in finely divided form and was removed by filtration,
washed with methanol and dried. This was molded into
disks at about l00°—125° C. which have useful dielectric
properties. These disks can be machined and used as in-
sulating washers. The polymer is soluble in acetone and
films or coatings can be made from -these solutions in
the usual manner. These also have useful electrical in-
sulating properties.
Example 3.——2-( 1, 1,1-trifluoro) propyl—2-cyanoacrylate
A 2-1. three-necked flask equipped with a mechanical
stirrer and Dean-Stark water trap was charged with 438
g. (2.42 moles) 2-( 1,1,1-trifluoro)propyl cyanoacetate,
96.0 g. (3.2 moles) powdered paraformaldehyde, 3.0 g.
piperidine hydrochloride, 0.5 ml. glacial acetic acid and
900 ml. benzene. The mixture was stirred and slowly
brought to reflux over a period of 3 hours. Heating under
reflux was continued until no more water separated in
the trap. The cooled solution of low molecular weight
polymer was then filtered into a round-bot-tomed flask con-
taining 240 g. tricresylphosphate. Benzene was then re-
moved by distillation. Last traces of solvent were elimi-
nated by stirring the mixture at 110° C./ 0.3 mm.
The distillation head was removed and replaced with a
clean, dry one-piece head and condenser fitted with a gas
inlet tube in the thermometer well. About 10 g. poly-
phosphoric acid were added to the orange syrupy mixture.
Thermal depolymerization was effected by heating this
mixture under reduced pressure while sulfur dioxide was
bled into the system. Collection of crude monomeric 2-
(1,l,1-trifluoro)propyl 2-cyanoacrylate in a Dry Ice-
cooled receiver was begun when the bath temperature/
system pressure reached 150° C./20 mm. and continued
up to a maximum of 190° C./0.45 mm.; yield, 251 g. On
redistillation of crude monomer from a small amount of
phosphorus pentoxide as described in Example 1, the
fraction boiling at 83°—85° C./ 17 mm. was shown to be
at least 98 percent pure 2-.(1,l,l-trifluoro)propyl cyano-
acrylate. The monomer is converted to polymer by the
procedure described in Example 1.
Examples of other 2-cyanoacrylates.—Other cyano-
acrylates which have been prepared in a manner similar
to that described in Examples 1 and 2 are collected in
Table II.
TABLE II
Fluoroalkyl 2-cyvanoacrylates
CN
/
CH2=C
\
CO2R
R: B.P.
—CH2(CF2)2H _________ __ 89—90°/0.3 mm.
——CH2(CF2)4H _________ -_ 91-95“/0.2-0.4 mm.
-—CH2CF2CF3 __________ __ 98—100°/ 15 mm.
These monomers can be polymerized in the same
manner as described in Examples 1 and 2.
3,639,361
7
Example 4.—-Hemostasis in vascular organs
(excised cat spleen)
A male cat was anesthetized intravenously with pento-
barbital-sodium and prepared for aseptic surgery. Prior
to surgery 25 milligrams of heparin sodium USP were
intravenously administered. The spleen was exteriorized
through a ventral midline incision, and a disk-shaped por-
tion of splenic tissue 1 to 2 centimeters in diameter and 3
-to 5 millimeters deep was excised. Resulting profuse
hemorrhage from the Wound was controlled by occluding
the blood supply to the spleen with soft clamps and gauze
sponging. A thin layer of 2,2,2-trifluoroethyl 2-cyano-
acrylate adhesive monomer was applied to the wound sur-
face immediately thereafter by spraying with an aerosol
at a distance of from 4 -to 8 centimeters from the wound
surface. After allowing suflicient time for polymerization
of the monomer, the organ was replaced in the peritoneal
cavity. The ventral midline incision was closed using con-
ventional sutures. Post-operative antibiotics and vitamins
were routinely administered. Adhesive and hemostatic
properties were recorded at the time of application.
The cat, except for depression during the first few post-
operative days, made an uneventful recovery and re-
mained healthy until sacrificed -six weeks after surgery.
Adhesions between the spleen and surrounding tissue, an
expected sequela following surgery of this nature, and‘
mild inflammation of the splenic capsule were the only
gross tissue’ changes observed at necropsy. None of the
adhesive was grossly visible and normal healing appeared
to be in progress. '
What is claimed is:
1. 2-(1,1,1-trifluoro)propy1 2-cyanoacrylate.
2. -1,1,3-trihydroperfluoropropyl 2-cyanoacrylate.
3. 1,l,5—trihydroperfluoropentyl 2-cyanoacrylate.
4. 1,1-dihydroperfluoropropyl 2-cyanoacrylate.
5. Composition according to claim 1 comprising addi-
tionally sulfur dioxide as polymerization inhilbitor.
6. Composition according to claim 2 comprising addi-
tionally sulfur dioxide as polymerization inhibitor.
7. Composition according to claim 3 comprising addi-
tionally sulfur dioxide as polymerization inhibitor.
8. Composition according to claim 4 comprising addi-
tionally sulfur dioxide as polymerization inhibitor.
9. A thermoplastic addition homopolymer of the mono-
mer of claim 1 having the general formula:
ioHz—o(cN)_'
L 02. J.
F3C—-J3—CHz
1%:
wherein x is 5 to 500.
UK
10
20
30
40
45
50
8
10. A thermoplastic addition homopolymer of the
monomer of claim 2 having the general formula:
3°” ‘
CH2C FzCF2H
wherein x is 5 to 500.
11. A thermoplastic addition homopolymer of the
monomer of claim 3 having the general formula:
-—|:CH2—C(CN)—-l—-
L I J.
(E0
CHz(CF)4H
wherein x is 5 to 500.
‘12. A thermoplastic addition homopolymer of the
monomer of claim 4 having the general formula:
__ (C-N)__
FCH C .-I
L ‘" 0 J.
(i‘,'HaCF2CF;
wherein x is 5 to 500.
References Cited
UNITED STATES PATENTS
2,765,332 10/ 1956‘ Coover et al. ____ __ 260—465.4
2,784,127 3/1957 Joyner et al _______ __ 260-88.7
2,794,788 6/1957 Coover et al. _____ .. 260—88.7
3,275,462 9/1966 Strobel et al. ____ __ 260—465.4
3,255,059 6/1966 Hamermesh et al .... __ 149-22
3,223,083 12/1965 Cobey _________ __ 260__78_4 N
3,282,773 11/1966 Wicker et al. ..____ 260--78.4 ‘N
3,360,124 12/1967 Stonehill _______ __ 260—78.4 N
3,483,870 12/ 1969 Coover et al. .._.___ 260—78.4 N
HARRY WONG, JR., Primary Examiner
U.S. Cl. X.R.
117—124, 132, 138.8; 128-156; 260-32.8, 78.5; 465.4
Coments go here:
- Log in to post comments